a lot of overdue milestones need to be addressed, along with recent updates. I made a list of some of the more significant subjects. hopefully light is shed on these before the end of the month.
—
HIV mAbs: should have finished testing in strasbourg 3 months ago and animal studies should be well underway (originally set to take place at national primate research center, new location [and status] unknown).
covid mAbs: production should have been completed in July or August and "fast-tracked" clinical studies should either be underway or already scheduled
HLTV-1/2 mAbs: should be either already successfully created or at least 80% progressed by now
HLTV-1 mAbs: update on the “letter of intent” that was signed with Creative Biolabs for licensing and commercialization of HLTV-1 mAbs (PR on 7/20)
ITV-1: update on the status of the previously reported “completed arrangements/agreements” with Dahnson & Clinic Design to advance ITV-1 to clinical trials (PR on 7/29)
Update on the distributorship license for ITV-1 that included a $2MM investment in exchange for Series E shares, $1MM cash, and 50% ownership of the undisclosed licensing entity that was valued (by someone) at $8MM
**also: status of audited financials and the currently ongoing lawsuits